Xenon Pharmaceuticals Stock Target Price and Analyst Consensus
| XENE Stock | USD 36.45 1.11 3.14% |
The current analyst and expert consensus on Xenon Pharmaceuticals is Strong Buy, with 11 strong buy opinions. The current projected Xenon Pharmaceuticals target price consensus is 57.67 with 16 analyst opinions. Check out Macroaxis Advice on Xenon Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Xenon Stock refer to our How to Trade Xenon Stock guide.The most common way Xenon Pharmaceuticals analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Xenon Pharmaceuticals executives and customers to further validate their buy or sell advice. Xenon Pharmaceuticals buy-or-sell recommendation module provides average expert sentiment on the projected Xenon Pharmaceuticals target price to derive its highest and lowest estimates based on projected price volatility of 1.954.
Lowest Forecast 52.48 | Highest Forecast 64.01 | Target Price 57.67 |
Xenon |
It's important to approach Xenon Pharmaceuticals' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Xenon Pharmaceuticals price targets
Xenon Pharmaceuticals' stock target price is an estimate of its future price, usually made by analysts. Using Xenon Pharmaceuticals' target price to determine if it is a suitable investment can be done through the following steps:- Look at Xenon Pharmaceuticals' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Xenon Pharmaceuticals' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Xenon Pharmaceuticals Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Xenon Pharmaceuticals is a key component of Xenon Pharmaceuticals valuation and have some predictive power on the future returns of a Xenon Pharmaceuticals.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Cancer Fighters Invested over 90 shares | |
 | Air Invested over 400 shares | |
 | Macroaxis Index Invested over 200 shares | |
 | Plastics Invested over 20 shares | |
 | Precious Metals Invested over 100 shares | |
 | Gold and Gold Mining Invested over 100 shares | |
 | Momentum Invested over 300 shares | |
 | SRI Sustainable Growth Invested few shares | |
 | Driverless Cars Invested few shares | |
 | Investor Favorites Invested over 300 shares | |
Check out Macroaxis Advice on Xenon Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Xenon Stock refer to our How to Trade Xenon Stock guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Please note, the presentation of Xenon Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Xenon Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Xenon Pharmaceuticals' management manipulating its earnings.